Rituximab plus cyclophosphamide and dexamethasone bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial.

Wenjie Xiong Rui Lyu Ying Yu Tingyu Wang Yuting Yan Yi Wang Wei Liu Gang An Shuhui Deng Yan Xu Weiwei Sui Wenyang Huang Dehui Zou Jianxiang Wang Lugui Qiu Shuhua Yi

Haematologica

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China; Tianjin Institutes of Health Science, Tianjin 301600.

Published: May 2024

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11063847	PMC
http://dx.doi.org/10.3324/haematol.2023.284588	DOI Listing

Publication Analysis

Top Keywords

cyclophosphamide dexamethasone

rituximab cyclophosphamide

dexamethasone bortezomib

bortezomib cyclophosphamide

dexamethasone newly

newly diagnosed

diagnosed symptomatic

symptomatic waldenström

waldenström macroglobulinemia

macroglobulinemia randomized

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!